VOYAGER (KSCC1902): A single-arm, multicenter, phase II study of early induction of nivolumab during second-line treatment with taxane +- ramucirumab for advanced gastric or gastro-esophageal junction cancer.
Nivolumab;Ramucirumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: VOYAGER (KSCC1902): A single-arm, multicenter, phase II study of early induction of nivolumab during second-line treatment with taxane +- ramucirumab for advanced gastric or gastro-esophageal junction cancer. ### Output: Nivolumab;Ramucirumab